Biopharma

Content related to Biopharma:

August-whitepaper-2017

Whitepaper: Development of an Efficient Manufacturing Process for Adenovirus

leukaemia

FDA grants approval of Besponsa for acute lymphoblastic leukaemia

By Dr Zara Kassam (European Pharmaceutical Review)

FDA

FDA grants two orphan drug designations for HCC

By Dr Zara Kassam (European Pharmaceutical Review)

European Pharmaceutical Review magazine issue 4 2017

Issue #4 2017 – Digital Version

By European Pharmaceutical Review

NICE

NICE approves three quarters of drugs from the Cancer Drugs Fund

By Dr Zara Kassam (European Pharmaceutical Review)

DNA Strand

SynBio: unlocking the commercial potential of a new bioscience industry

By Magda Papadaki

India’s

India’s pharmaceutical market set to hit $100bn by 2025

By Vanaja Krishnan

Bayer

Bayer receives EU approval for Regorafenib

By Dr Zara Kassam (European Pharmaceutical Review)

Infoholics

Infoholics reports growth for polymerase chain reaction market

By Dr Zara Kassam (European Pharmaceutical Review)

hepatitis C

FDA approves AbbVie’s Mavyret for hepatitis C

By Dr Zara Kassam (European Pharmaceutical Review)

Biopharma

Biopharma stages a strong recovery

By Dr Zara Kassam (European Pharmaceutical Review)

New gasket and braided hose range from BioPure sets the new standard for confident fluid path validation

By Watson-Marlow Fluid Technology Group

FDA

FDA approves new targeted treatment for acute myeloid leukemia

By Dr Zara Kassam (European Pharmaceutical Review)

FT conference 2017

The return of the FT Global Pharmaceutical and Biotechnology Conference

By Financial Times

BIOCAD Biotech business

BIOCAD does its sums for growth

By Steve Bremer (European Pharmaceutical Review)

Page 1 of 32
1
2
3
4
5
6
7
8
9
10
...
32
>

© Russell Publishing Limited, 2010-2017. All rights reserved.

Website development by e-Motive Media Limited.

Send this to a friend

Your emailRecipient emailYour messageWhat colour is grass?